HEADER HYDROLASE/HYDROLASE INHIBITOR 21-MAY-21 7MYU TITLE BACE-1 IN COMPLEX WITH COMPOUND #22 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-SECRETASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ASPARTYL PROTEASE 2,ASP 2,BETA-SITE AMYLOID PRECURSOR COMPND 5 PROTEIN CLEAVING ENZYME 1,BETA-SITE APP CLEAVING ENZYME 1,MEMAPSIN-2, COMPND 6 MEMBRANE-ASSOCIATED ASPARTIC PROTEASE 2; COMPND 7 EC: 3.4.23.46; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BACE1, BACE, KIAA1149; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.HENDLE,D.E.TIMM,S.L.STOUT REVDAT 2 18-OCT-23 7MYU 1 REMARK REVDAT 1 21-JUL-21 7MYU 0 JRNL AUTH D.L.MCKINZIE,L.L.WINNEROSKI,S.J.GREEN,E.J.HEMBRE, JRNL AUTH 2 J.A.ERICKSON,B.A.WILLIS,S.A.MONK,C.D.ALUISE,T.K.BAKER, JRNL AUTH 3 J.E.LOPEZ,J.HENDLE,J.P.BECK,R.A.BRIER,L.N.BOGGS,A.R.BORDERS, JRNL AUTH 4 P.J.COCKE,P.GARCIA-LOSADA,S.L.LOWE,B.M.MATHES,P.C.MAY, JRNL AUTH 5 W.J.PORTER,S.L.STOUT,D.E.TIMM,B.M.WATSON,Z.YANG,D.J.MERGOTT JRNL TITL DISCOVERY AND EARLY CLINICAL DEVELOPMENT OF LY3202626, A JRNL TITL 2 LOW-DOSE, CNS-PENETRANT BACE INHIBITOR. JRNL REF J.MED.CHEM. V. 64 8076 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34081466 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00489 REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0103 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 76070 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 0.700 REMARK 3 FREE R VALUE TEST SET COUNT : 518 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.94 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.99 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5553 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.34 REMARK 3 BIN R VALUE (WORKING SET) : 0.2940 REMARK 3 BIN FREE R VALUE SET COUNT : 35 REMARK 3 BIN FREE R VALUE : 0.3370 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6067 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 75 REMARK 3 SOLVENT ATOMS : 730 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.19000 REMARK 3 B22 (A**2) : 0.94000 REMARK 3 B33 (A**2) : -0.75000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.138 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.134 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.104 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.817 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6448 ; 0.006 ; 0.012 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8821 ; 1.179 ; 1.652 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 824 ; 7.210 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 286 ;34.407 ;23.846 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1010 ;12.697 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 36 ;18.635 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 837 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5132 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7MYU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-MAY-21. REMARK 100 THE DEPOSITION ID IS D_1000257041. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAR-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97931 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 76824 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.940 REMARK 200 RESOLUTION RANGE LOW (A) : 34.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.15500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.04 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 7.10 REMARK 200 R MERGE FOR SHELL (I) : 0.70800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 6UVP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM SODIUM CACODYLATE PH 7.4, 12% REMARK 280 PEG 8K, 200MM AMMONIUM SULFATE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 43.25800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.54100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.27000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.54100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.25800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.27000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -48 REMARK 465 ALA A -47 REMARK 465 GLY A -46 REMARK 465 VAL A -45 REMARK 465 LEU A -44 REMARK 465 PRO A -43 REMARK 465 ALA A -42 REMARK 465 HIS A -41 REMARK 465 GLY A -40 REMARK 465 THR A -39 REMARK 465 GLN A -38 REMARK 465 HIS A -37 REMARK 465 GLY A -36 REMARK 465 ILE A -35 REMARK 465 ARG A -34 REMARK 465 LEU A -33 REMARK 465 PRO A -32 REMARK 465 LEU A -31 REMARK 465 ARG A -30 REMARK 465 SER A -29 REMARK 465 GLY A -28 REMARK 465 LEU A -27 REMARK 465 GLY A -26 REMARK 465 GLY A -25 REMARK 465 ALA A -24 REMARK 465 PRO A -23 REMARK 465 LEU A -22 REMARK 465 GLY A -21 REMARK 465 LEU A -20 REMARK 465 ARG A -19 REMARK 465 LEU A -18 REMARK 465 PRO A -17 REMARK 465 ARG A -16 REMARK 465 GLU A -15 REMARK 465 THR A -14 REMARK 465 ASP A -13 REMARK 465 GLU A -12 REMARK 465 GLU A -11 REMARK 465 PRO A -10 REMARK 465 GLU A -9 REMARK 465 GLU A -8 REMARK 465 PRO A -7 REMARK 465 GLY A -6 REMARK 465 ARG A -5 REMARK 465 ILE A 386 REMARK 465 PRO A 387 REMARK 465 GLN A 388 REMARK 465 THR A 389 REMARK 465 ASP A 390 REMARK 465 GLU A 391 REMARK 465 SER A 392 REMARK 465 THR A 393 REMARK 465 MET B -48 REMARK 465 ALA B -47 REMARK 465 GLY B -46 REMARK 465 VAL B -45 REMARK 465 LEU B -44 REMARK 465 PRO B -43 REMARK 465 ALA B -42 REMARK 465 HIS B -41 REMARK 465 GLY B -40 REMARK 465 THR B -39 REMARK 465 GLN B -38 REMARK 465 HIS B -37 REMARK 465 GLY B -36 REMARK 465 ILE B -35 REMARK 465 ARG B -34 REMARK 465 LEU B -33 REMARK 465 PRO B -32 REMARK 465 LEU B -31 REMARK 465 ARG B -30 REMARK 465 SER B -29 REMARK 465 GLY B -28 REMARK 465 LEU B -27 REMARK 465 GLY B -26 REMARK 465 GLY B -25 REMARK 465 ALA B -24 REMARK 465 PRO B -23 REMARK 465 LEU B -22 REMARK 465 GLY B -21 REMARK 465 LEU B -20 REMARK 465 ARG B -19 REMARK 465 LEU B -18 REMARK 465 PRO B -17 REMARK 465 ARG B -16 REMARK 465 GLU B -15 REMARK 465 THR B -14 REMARK 465 ASP B -13 REMARK 465 GLU B -12 REMARK 465 GLU B -11 REMARK 465 PRO B -10 REMARK 465 GLU B -9 REMARK 465 GLU B -8 REMARK 465 PRO B -7 REMARK 465 GLY B -6 REMARK 465 ARG B -5 REMARK 465 ARG B -4 REMARK 465 ILE B 386 REMARK 465 PRO B 387 REMARK 465 GLN B 388 REMARK 465 THR B 389 REMARK 465 ASP B 390 REMARK 465 GLU B 391 REMARK 465 SER B 392 REMARK 465 THR B 393 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 49 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 73 CG CD OE1 NE2 REMARK 470 GLN A 163 CG CD OE1 NE2 REMARK 470 VAL A 312 CG1 CG2 REMARK 470 THR A 314 OG1 CG2 REMARK 470 ASP A 378 CG OD1 OD2 REMARK 470 GLU A 380 CG CD OE1 OE2 REMARK 470 HIS B 49 CG ND1 CD2 CE1 NE2 REMARK 470 GLN B 73 CG CD OE1 NE2 REMARK 470 GLN B 163 CG CD OE1 NE2 REMARK 470 VAL B 312 CG1 CG2 REMARK 470 THR B 314 OG1 CG2 REMARK 470 ASP B 378 CG OD1 OD2 REMARK 470 GLU B 380 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 4 30.42 74.80 REMARK 500 HIS A 89 60.13 -103.42 REMARK 500 PHE A 108 -60.79 -93.94 REMARK 500 ASN A 114 14.34 82.44 REMARK 500 TRP A 197 -82.73 -138.83 REMARK 500 HIS B 89 43.51 -104.11 REMARK 500 PHE B 108 -61.03 -96.83 REMARK 500 TRP B 197 -83.09 -136.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 866 DISTANCE = 6.15 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7MYI RELATED DB: PDB REMARK 900 RELATED ID: 7MYR RELATED DB: PDB DBREF 7MYU A -47 393 UNP P56817 BACE1_HUMAN 14 454 DBREF 7MYU B -47 393 UNP P56817 BACE1_HUMAN 14 454 SEQADV 7MYU MET A -48 UNP P56817 EXPRESSION TAG SEQADV 7MYU MET B -48 UNP P56817 EXPRESSION TAG SEQRES 1 A 442 MET ALA GLY VAL LEU PRO ALA HIS GLY THR GLN HIS GLY SEQRES 2 A 442 ILE ARG LEU PRO LEU ARG SER GLY LEU GLY GLY ALA PRO SEQRES 3 A 442 LEU GLY LEU ARG LEU PRO ARG GLU THR ASP GLU GLU PRO SEQRES 4 A 442 GLU GLU PRO GLY ARG ARG GLY SER PHE VAL GLU MET VAL SEQRES 5 A 442 ASP ASN LEU ARG GLY LYS SER GLY GLN GLY TYR TYR VAL SEQRES 6 A 442 GLU MET THR VAL GLY SER PRO PRO GLN THR LEU ASN ILE SEQRES 7 A 442 LEU VAL ASP THR GLY SER SER ASN PHE ALA VAL GLY ALA SEQRES 8 A 442 ALA PRO HIS PRO PHE LEU HIS ARG TYR TYR GLN ARG GLN SEQRES 9 A 442 LEU SER SER THR TYR ARG ASP LEU ARG LYS GLY VAL TYR SEQRES 10 A 442 VAL PRO TYR THR GLN GLY LYS TRP GLU GLY GLU LEU GLY SEQRES 11 A 442 THR ASP LEU VAL SER ILE PRO HIS GLY PRO ASN VAL THR SEQRES 12 A 442 VAL ARG ALA ASN ILE ALA ALA ILE THR GLU SER ASP LYS SEQRES 13 A 442 PHE PHE ILE ASN GLY SER ASN TRP GLU GLY ILE LEU GLY SEQRES 14 A 442 LEU ALA TYR ALA GLU ILE ALA ARG PRO ASP ASP SER LEU SEQRES 15 A 442 GLU PRO PHE PHE ASP SER LEU VAL LYS GLN THR HIS VAL SEQRES 16 A 442 PRO ASN LEU PHE SER LEU GLN LEU CYS GLY ALA GLY PHE SEQRES 17 A 442 PRO LEU ASN GLN SER GLU VAL LEU ALA SER VAL GLY GLY SEQRES 18 A 442 SER MET ILE ILE GLY GLY ILE ASP HIS SER LEU TYR THR SEQRES 19 A 442 GLY SER LEU TRP TYR THR PRO ILE ARG ARG GLU TRP TYR SEQRES 20 A 442 TYR GLU VAL ILE ILE VAL ARG VAL GLU ILE ASN GLY GLN SEQRES 21 A 442 ASP LEU LYS MET ASP CYS LYS GLU TYR ASN TYR ASP LYS SEQRES 22 A 442 SER ILE VAL ASP SER GLY THR THR ASN LEU ARG LEU PRO SEQRES 23 A 442 LYS LYS VAL PHE GLU ALA ALA VAL LYS SER ILE LYS ALA SEQRES 24 A 442 ALA SER SER THR GLU LYS PHE PRO ASP GLY PHE TRP LEU SEQRES 25 A 442 GLY GLU GLN LEU VAL CYS TRP GLN ALA GLY THR THR PRO SEQRES 26 A 442 TRP ASN ILE PHE PRO VAL ILE SER LEU TYR LEU MET GLY SEQRES 27 A 442 GLU VAL THR ASN GLN SER PHE ARG ILE THR ILE LEU PRO SEQRES 28 A 442 GLN GLN TYR LEU ARG PRO VAL GLU ASP VAL ALA THR SER SEQRES 29 A 442 GLN ASP ASP CYS TYR LYS PHE ALA ILE SER GLN SER SER SEQRES 30 A 442 THR GLY THR VAL MET GLY ALA VAL ILE MET GLU GLY PHE SEQRES 31 A 442 TYR VAL VAL PHE ASP ARG ALA ARG LYS ARG ILE GLY PHE SEQRES 32 A 442 ALA VAL SER ALA CYS HIS VAL HIS ASP GLU PHE ARG THR SEQRES 33 A 442 ALA ALA VAL GLU GLY PRO PHE VAL THR LEU ASP MET GLU SEQRES 34 A 442 ASP CYS GLY TYR ASN ILE PRO GLN THR ASP GLU SER THR SEQRES 1 B 442 MET ALA GLY VAL LEU PRO ALA HIS GLY THR GLN HIS GLY SEQRES 2 B 442 ILE ARG LEU PRO LEU ARG SER GLY LEU GLY GLY ALA PRO SEQRES 3 B 442 LEU GLY LEU ARG LEU PRO ARG GLU THR ASP GLU GLU PRO SEQRES 4 B 442 GLU GLU PRO GLY ARG ARG GLY SER PHE VAL GLU MET VAL SEQRES 5 B 442 ASP ASN LEU ARG GLY LYS SER GLY GLN GLY TYR TYR VAL SEQRES 6 B 442 GLU MET THR VAL GLY SER PRO PRO GLN THR LEU ASN ILE SEQRES 7 B 442 LEU VAL ASP THR GLY SER SER ASN PHE ALA VAL GLY ALA SEQRES 8 B 442 ALA PRO HIS PRO PHE LEU HIS ARG TYR TYR GLN ARG GLN SEQRES 9 B 442 LEU SER SER THR TYR ARG ASP LEU ARG LYS GLY VAL TYR SEQRES 10 B 442 VAL PRO TYR THR GLN GLY LYS TRP GLU GLY GLU LEU GLY SEQRES 11 B 442 THR ASP LEU VAL SER ILE PRO HIS GLY PRO ASN VAL THR SEQRES 12 B 442 VAL ARG ALA ASN ILE ALA ALA ILE THR GLU SER ASP LYS SEQRES 13 B 442 PHE PHE ILE ASN GLY SER ASN TRP GLU GLY ILE LEU GLY SEQRES 14 B 442 LEU ALA TYR ALA GLU ILE ALA ARG PRO ASP ASP SER LEU SEQRES 15 B 442 GLU PRO PHE PHE ASP SER LEU VAL LYS GLN THR HIS VAL SEQRES 16 B 442 PRO ASN LEU PHE SER LEU GLN LEU CYS GLY ALA GLY PHE SEQRES 17 B 442 PRO LEU ASN GLN SER GLU VAL LEU ALA SER VAL GLY GLY SEQRES 18 B 442 SER MET ILE ILE GLY GLY ILE ASP HIS SER LEU TYR THR SEQRES 19 B 442 GLY SER LEU TRP TYR THR PRO ILE ARG ARG GLU TRP TYR SEQRES 20 B 442 TYR GLU VAL ILE ILE VAL ARG VAL GLU ILE ASN GLY GLN SEQRES 21 B 442 ASP LEU LYS MET ASP CYS LYS GLU TYR ASN TYR ASP LYS SEQRES 22 B 442 SER ILE VAL ASP SER GLY THR THR ASN LEU ARG LEU PRO SEQRES 23 B 442 LYS LYS VAL PHE GLU ALA ALA VAL LYS SER ILE LYS ALA SEQRES 24 B 442 ALA SER SER THR GLU LYS PHE PRO ASP GLY PHE TRP LEU SEQRES 25 B 442 GLY GLU GLN LEU VAL CYS TRP GLN ALA GLY THR THR PRO SEQRES 26 B 442 TRP ASN ILE PHE PRO VAL ILE SER LEU TYR LEU MET GLY SEQRES 27 B 442 GLU VAL THR ASN GLN SER PHE ARG ILE THR ILE LEU PRO SEQRES 28 B 442 GLN GLN TYR LEU ARG PRO VAL GLU ASP VAL ALA THR SER SEQRES 29 B 442 GLN ASP ASP CYS TYR LYS PHE ALA ILE SER GLN SER SER SEQRES 30 B 442 THR GLY THR VAL MET GLY ALA VAL ILE MET GLU GLY PHE SEQRES 31 B 442 TYR VAL VAL PHE ASP ARG ALA ARG LYS ARG ILE GLY PHE SEQRES 32 B 442 ALA VAL SER ALA CYS HIS VAL HIS ASP GLU PHE ARG THR SEQRES 33 B 442 ALA ALA VAL GLU GLY PRO PHE VAL THR LEU ASP MET GLU SEQRES 34 B 442 ASP CYS GLY TYR ASN ILE PRO GLN THR ASP GLU SER THR HET ZR7 A 401 35 HET ZR7 B 401 35 HET SO4 B 402 5 HETNAM ZR7 N-{3-[(4AR,7AS)-2-AMINO-6-(5-FLUOROPYRIMIDIN-2-YL)-4A, HETNAM 2 ZR7 5,6,7-TETRAHYDROPYRROLO[3,4-D][1,3]THIAZIN-7A(4H)-YL]- HETNAM 3 ZR7 4-FLUOROPHENYL}-5-METHOXYPYRAZINE-2-CARBOXAMIDE HETNAM SO4 SULFATE ION FORMUL 3 ZR7 2(C22 H20 F2 N8 O2 S) FORMUL 5 SO4 O4 S 2- FORMUL 6 HOH *730(H2 O) HELIX 1 AA1 GLN A 53 SER A 57 5 5 HELIX 2 AA2 TYR A 123 ALA A 127 5 5 HELIX 3 AA3 PRO A 135 THR A 144 1 10 HELIX 4 AA4 ASN A 162 SER A 169 1 8 HELIX 5 AA5 ASP A 180 SER A 182 5 3 HELIX 6 AA6 ASP A 216 TYR A 222 5 7 HELIX 7 AA7 LYS A 238 SER A 252 1 15 HELIX 8 AA8 PRO A 258 LEU A 263 1 6 HELIX 9 AA9 PRO A 276 PHE A 280 5 5 HELIX 10 AB1 LEU A 301 TYR A 305 1 5 HELIX 11 AB2 GLY A 334 GLU A 339 1 6 HELIX 12 AB3 ARG A 347 ARG A 349 5 3 HELIX 13 AB4 ASP A 378 GLY A 383 5 6 HELIX 14 AB5 GLN B 53 SER B 57 5 5 HELIX 15 AB6 TYR B 123 ALA B 127 5 5 HELIX 16 AB7 PRO B 135 THR B 144 1 10 HELIX 17 AB8 ASN B 162 SER B 169 1 8 HELIX 18 AB9 ASP B 180 SER B 182 5 3 HELIX 19 AC1 ASP B 216 TYR B 222 5 7 HELIX 20 AC2 LYS B 238 SER B 252 1 15 HELIX 21 AC3 PRO B 258 LEU B 263 1 6 HELIX 22 AC4 PRO B 276 PHE B 280 5 5 HELIX 23 AC5 LEU B 301 TYR B 305 1 5 HELIX 24 AC6 GLY B 334 GLU B 339 1 6 HELIX 25 AC7 MET B 379 GLY B 383 5 5 SHEET 1 AA1 8 LEU A 6 LYS A 9 0 SHEET 2 AA1 8 GLY A 13 VAL A 20 -1 O GLY A 13 N LYS A 9 SHEET 3 AA1 8 GLN A 25 ASP A 32 -1 O LEU A 27 N MET A 18 SHEET 4 AA1 8 GLY A 117 GLY A 120 1 O LEU A 119 N LEU A 30 SHEET 5 AA1 8 PHE A 38 GLY A 41 -1 N ALA A 39 O ILE A 118 SHEET 6 AA1 8 VAL A 95 ASP A 106 1 O ILE A 102 N VAL A 40 SHEET 7 AA1 8 GLY A 74 SER A 86 -1 N GLU A 77 O GLU A 104 SHEET 8 AA1 8 ARG A 61 TYR A 71 -1 N LYS A 65 O LEU A 80 SHEET 1 AA2 4 LEU A 6 LYS A 9 0 SHEET 2 AA2 4 GLY A 13 VAL A 20 -1 O GLY A 13 N LYS A 9 SHEET 3 AA2 4 GLY A 74 SER A 86 -1 O SER A 86 N THR A 19 SHEET 4 AA2 4 ARG A 61 TYR A 71 -1 N LYS A 65 O LEU A 80 SHEET 1 AA3 5 GLY A 172 ILE A 176 0 SHEET 2 AA3 5 PHE A 150 LEU A 154 -1 N GLN A 153 O SER A 173 SHEET 3 AA3 5 PHE A 341 ASP A 346 -1 O PHE A 345 N PHE A 150 SHEET 4 AA3 5 ARG A 351 SER A 357 -1 O ALA A 355 N TYR A 342 SHEET 5 AA3 5 TYR A 184 PRO A 192 -1 N THR A 191 O ILE A 352 SHEET 1 AA4 5 GLU A 200 VAL A 201 0 SHEET 2 AA4 5 SER A 225 VAL A 227 -1 O SER A 225 N VAL A 201 SHEET 3 AA4 5 THR A 331 MET A 333 1 O MET A 333 N ILE A 226 SHEET 4 AA4 5 LEU A 234 PRO A 237 -1 N ARG A 235 O VAL A 332 SHEET 5 AA4 5 ILE A 324 SER A 327 1 O SER A 325 N LEU A 236 SHEET 1 AA5 5 GLN A 211 ASP A 212 0 SHEET 2 AA5 5 ILE A 203 ILE A 208 -1 N ILE A 208 O GLN A 211 SHEET 3 AA5 5 ILE A 283 MET A 288 -1 O TYR A 286 N ARG A 205 SHEET 4 AA5 5 GLN A 294 ILE A 300 -1 O ILE A 298 N LEU A 285 SHEET 5 AA5 5 ALA A 369 VAL A 375 -1 O GLU A 371 N ARG A 297 SHEET 1 AA6 3 VAL A 268 TRP A 270 0 SHEET 2 AA6 3 ASP A 318 PHE A 322 -1 O ASP A 318 N TRP A 270 SHEET 3 AA6 3 LEU A 306 VAL A 309 -1 N ARG A 307 O LYS A 321 SHEET 1 AA7 8 LEU B 6 LYS B 9 0 SHEET 2 AA7 8 GLY B 13 VAL B 20 -1 O TYR B 15 N ARG B 7 SHEET 3 AA7 8 GLN B 25 ASP B 32 -1 O LEU B 27 N MET B 18 SHEET 4 AA7 8 GLY B 117 GLY B 120 1 O LEU B 119 N LEU B 30 SHEET 5 AA7 8 PHE B 38 GLY B 41 -1 N ALA B 39 O ILE B 118 SHEET 6 AA7 8 VAL B 95 ASP B 106 1 O ILE B 102 N VAL B 40 SHEET 7 AA7 8 GLY B 74 SER B 86 -1 N GLU B 79 O ALA B 101 SHEET 8 AA7 8 ARG B 61 TYR B 71 -1 N LYS B 65 O LEU B 80 SHEET 1 AA8 4 LEU B 6 LYS B 9 0 SHEET 2 AA8 4 GLY B 13 VAL B 20 -1 O TYR B 15 N ARG B 7 SHEET 3 AA8 4 GLY B 74 SER B 86 -1 O SER B 86 N THR B 19 SHEET 4 AA8 4 ARG B 61 TYR B 71 -1 N LYS B 65 O LEU B 80 SHEET 1 AA9 5 GLY B 172 ILE B 176 0 SHEET 2 AA9 5 PHE B 150 LEU B 154 -1 N GLN B 153 O SER B 173 SHEET 3 AA9 5 PHE B 341 ASP B 346 -1 O PHE B 345 N PHE B 150 SHEET 4 AA9 5 ARG B 351 SER B 357 -1 O ALA B 355 N TYR B 342 SHEET 5 AA9 5 TYR B 184 PRO B 192 -1 N THR B 191 O ILE B 352 SHEET 1 AB1 5 GLU B 200 VAL B 201 0 SHEET 2 AB1 5 SER B 225 VAL B 227 -1 O SER B 225 N VAL B 201 SHEET 3 AB1 5 THR B 331 MET B 333 1 O MET B 333 N ILE B 226 SHEET 4 AB1 5 LEU B 234 PRO B 237 -1 N ARG B 235 O VAL B 332 SHEET 5 AB1 5 ILE B 324 SER B 327 1 O SER B 325 N LEU B 236 SHEET 1 AB2 5 GLN B 211 ASP B 212 0 SHEET 2 AB2 5 ILE B 203 ILE B 208 -1 N ILE B 208 O GLN B 211 SHEET 3 AB2 5 ILE B 283 MET B 288 -1 O TYR B 286 N ARG B 205 SHEET 4 AB2 5 GLN B 294 ILE B 300 -1 O ILE B 300 N ILE B 283 SHEET 5 AB2 5 ALA B 369 VAL B 375 -1 O GLU B 371 N ARG B 297 SHEET 1 AB3 3 VAL B 268 TRP B 270 0 SHEET 2 AB3 3 ASP B 318 PHE B 322 -1 O ASP B 318 N TRP B 270 SHEET 3 AB3 3 LEU B 306 VAL B 309 -1 N ARG B 307 O LYS B 321 SSBOND 1 CYS A 155 CYS A 359 1555 1555 2.11 SSBOND 2 CYS A 217 CYS A 382 1555 1555 2.08 SSBOND 3 CYS A 269 CYS A 319 1555 1555 2.10 SSBOND 4 CYS B 155 CYS B 359 1555 1555 2.11 SSBOND 5 CYS B 217 CYS B 382 1555 1555 2.06 SSBOND 6 CYS B 269 CYS B 319 1555 1555 2.09 CISPEP 1 SER A 22 PRO A 23 0 -5.23 CISPEP 2 ARG A 128 PRO A 129 0 12.42 CISPEP 3 ARG A 128 PRO A 129 0 10.97 CISPEP 4 TYR A 222 ASP A 223 0 11.80 CISPEP 5 GLY A 372 PRO A 373 0 0.53 CISPEP 6 SER B 22 PRO B 23 0 -5.36 CISPEP 7 ARG B 128 PRO B 129 0 6.23 CISPEP 8 TYR B 222 ASP B 223 0 9.24 CISPEP 9 GLY B 372 PRO B 373 0 -1.12 CRYST1 86.516 90.540 131.082 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011559 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011045 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007629 0.00000